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correlation was found with time to repedus~on (r=O.llO; ~~0.20). A significant correlation in UA patients significantly increased neutrophil apoptotic rate (36%; 21.47%. p=O.O06 vs 
was also observed between AEDV and peak creatine-kinase (p=O.O04; r=-0.649). baseline); moreover apoptotic rate following abciximab was not different from that 
CONCLUSIONS: The presence of an adequate, even though non-angiographically evi- observed in SA and healthy subjects. Conclusions. Our study demonstrates that Abcix- 
dent collateral flow may reduce microvascular damage in the setting of AMI treated with imab increases PMN apoptotic rate in patients with severe UA. Such increased blood 
primary PTCA, thus favouring ContractlIe recovery and preventing left ventricular remod- clearance of circulating PMN represents a novel anb-inflammatory mechanism of Abcix- 
cling. imab. 
1096-l 07 Rates of Diagnosis of Acute Myocardial Infarction 
Utilizing Cardiac Troponin-I or Creatine Kinase MB 
1096-110 A Gene Switch to Amplify the Expression of Multiple 
Genes Specifically in Cardiomyocytes Under Hypoxia 
Joseph C. Lln, Fred S. Apple, MaryAnn M. Murakami, Russell V. Luepker, Hennepin 
Countv Medical Center, Minneaoolis. MN, Universitv of Minnesota School of Public 
Health, Minneapolis, MN 
YiTana Keping Qian, Ian M. Phillips, Untversity of Florida, Gainesville, FL 
Background: One of the challenges for gene therapies IS to be able to switch on or off 
gene expression, ideally by a pathophysiological stimulus. For the purpose of treating 
myocardial ischemia, we have used hypoxia as the stimulus. Hypoxia-inducible factor 1 a 
(HIF-la ) is the master regulator for hypoxia rasponsas. Its protein stability is regulated 
by its oxygen-dependent degradation (ODD) domaln, which triggers a proteosome-medi- 
ated degradation only under normoxia. Therefore, we invented an oxygen-sensitive regu- 
lator (OSR) as hypoxic gene switch by fusing the ODD domain in between the DNA 
binding domain of yeast GAL4 and the activation domain of ~65. 
Method: The OSR recognizes and activates a minimal promoter containing GAL4 
upstream activating sequences. Three reporter genes. luciferase. p -galactosldase and 
secreted alkaline phosphatase were inserted downstream of this minimal promoter, 
respectively. The myosin light chain-2v (MLC-2~) promoter was used to restrict the 
expression of OSR in the heart. The plasmids were co-transfected into embryonic and 
adult rat cardiomyocyies and tested under hypoxia (1% Q or 0.5% 02) and normoxia 
(20% 0,). 
Results: After transfection, the expression of tuciferase was induced under hypoxia 3 to 
6 fold in embryonic cardiomyocytes and 16 fold in adult cardiomyocytes. When three dlf- 
ferent reporter plasmids were co-transfected with OSR. all of them were up-regulated 16 
to 18 fold by hypoxia. The OSR could rapidly turn on gene expression with the hypoxic 
stimulus and turn it off after normal air was restored. Furthermore, the OSR dramatically 
amplified the power of the MLC-2~ promoter up to 300-fold but still maintained its cardiac 
specificity. 
Conclusion: The OSR invented in current study is a novel oxygen sensor and gene 
amplifier. more effective than either HIF-1 or hypoxia response element in switching on 
and amplifying a cardiac specific promoter. It can be adapted into an adeno-associated 
virus mediated ‘“vigilant vector” to deliver multiple protective genes to the heart, such as 
heme oxygenase-1, superoxide dismutase. and VEGF, and simultaneously turn them on 
in response to ischemla and off in normoxia. 
BACKGROUND: Cardiac troponln-I (cTnl) IS a more specific and sensitive biomarker 
than creatine kinase MB (CK-MB) for detection of myocardial damage. However, the 
impact of cTnl versus CK-MB on the rates of diagnosis of acute myccardial infarction 
(AMI) is unclear. 
METHODS Seven hundred seventy-six consecutive hospital admissions for suspected 
acute coronarv syndrome (ACS) to an urban acute care hospital over a four month period 
were analyzed Patients were aged 16 to 84, residents of the seven-county Twin Cities 
metropolitan area. and had at least two separate sets of plasma biomarkers sent to the 
laboratory for evaluation of possible AMI during each hospital admission. cTnl and CK- 
MB assays (Dade Dimension) were performed concurrently. 
RESULTS: Using the 10% coefficient of variation (CV) cut-off adopted by the hospital 
(cTnl > 0.3 ng/mL and CK-MB > 5.0 ng/mL), 116 (14.9%) of the 776 consecutive ACS 
admlssions had positive cTnl. Of these, only 58 (50%) had positive CK-MB. Using a 99th 
percentile cut-off (cTnl > 0.1 ng/mL and CK-MB > 4.0 ng/mL) instead of the 10% CV cut- 
off would increase the number of CT&positive, CK-MB-negative admissions by 123%. 
Using the receiver operator charactenstic curve-derived cut-off (cTnl > 0.6 ng/mL and 
CK-MB > 7.0 ng/mL) Instead of the 10% CV cut-off would decrease the number of cTnl- 
positive, CK-MB-negative admissions by 27%. 
CONCLUSION: Rates of diagnosis of AMI as determined by plasma biomarkers are sub- 
stantially increased by criteria utilizmg cTnl compared to those utilizing CK-MB. Utilizing 
lower reference cut-offs for these plasma biomarkers markedly increases the rates of 
cTnl-positive, CK-MB-negative cases. 
1096-108 Reconstituted High-Density Lipoprotein Restores 
Endothelial Function in Acute Coronary Syndrome 
Remv Chenevard, David Huerlimann, Markus Bechir, lrmgard Andresen, Frank 
Ruschitzka. Thomas F. Luscher. Georg Nell, University Hospital, Zurich, Switzerland 
disease. In this study we tested the hypothesis wether reconstituted high density lipopro- 
tein (rHDL) can alter endothelial function I” patients diagnosed with ACS. 
Methods Measurements Included (I) venous occlusion plethysmography with acetylcho- 
Bapkground Acute Coronary Syndrome (ACS) is associated with severe impairment of 
endothellal function which correlates well with clinical outcome. Elevated levels of high 
density lipoprotein have long been recognized as a protective factor in cardiovascular 
Giuseppe Calvefi Carlo N. Dajelll Ermolli, Ylenia Beltelli, Salvatore Calco, Albert0 
Limido, Jorge A. Uriarte-Salerno, University of Insubria, Varese. Italy 
Can Preinfarction Angina Limit Infarct Size in Patients 
With a First Q-Wave Myocardial Infarction Undergoing 
Primary Percutaneous Coronary Angioplasty? 
1096-l 11 
line (ACH) as an endothellum-dependent vasodilator, nitroglycerine (NG) as direct dilator 
of vascular smooth muscle cells, results beeing expressed as ml flow per 100 ml tissue; 
and (2) positron emission tomography (PET) to assess myocardial perfusion at rest and 
during stress with adenosine, results beeing expressed as ratio of flow under stress/at 
rest. Experiments were performed before and after infusion of 80 mg rHDL per kg body 
weight and took place wlthin 7 days after diagnosis of ACS. All patients underwent percu- 
taneous coronary intervention prior to randomization and were an current standard med- 
ical treatment. 
Results 16 patients were included. ACH induced flow increased significantly after Infu- 
sion of rHDL (6.5 mllmin *2 to 8.0 mlimin ~2.4. p=O.O45). NG-induced blood flow too 
increased under rHDL as did PET assessed coronary flow reserve (11 mllmin e2.6 to 
14.5 mllmin +2.7. p=O.O3 and 1.2 +O.l versus 2.0 kO.3, p=O.O18). Hemodynamlc param- 
eters like mean arterial pressure and heart rate remained unchanged (73 mmHg versus 
72 mmHg and 64 bpm versus 64 bpm). rHDL infuston was well tolerated in all patients. 
Conclusions rHDL on top of standard treatment increased vascular reagibility I” patients 
diagnosed with ACS. rHDL possesses pkitropic effects, its anti-inflammatory component 
may be the most potent as acute inflammation - measured for example as c-reactive 
protein IS a diagnostic key factor in the outcome of ACS. Despite endothelial function 
being an excellent surrogate, prospective clinical trials are needed in order to unravel the 
true potential of rHDL as novel treatment option. 
1096-109 Abciximab Modulates Apoptosis of Circulating 
Neutrophils in Patients With Unstable Angina 
Antonino Buffon, Annalisa Porte, Giovanna Liuzzo. Antonella D’Annolfo. Donatella 
Lomaglio, Mlchela Pinnelli. Antonio G. Rebuzzi, Aniko Maseri, Luigi M. Biasucci, Filippo 
Crea, lnsitute of Cardiology-Catholic University, Rome, Italy 
Background. Activated neutrophils have been found !n the coronary circulation of unsta- 
ble angina (UA) patients. Neutrophil apoptosis. a key mechanism to control the intensity 
of the acute inflammatory response, is markedly reduced in unstable angina (UA) 
BACKGROUND: In patients with acute myocardial infarction (AMI), preinfarction angina 
(PA) promotes protective effects in the ischaemic myocardium, reducing the necrosis 
extension, but its impact in patients treated with primary percutaneous coronary angio- 
plasty with stem deployment (PTST) is not already defined. 
METHODS: We studied 163 patients (mean age 66.4 years, 26.6% female), hospitalised 
in our coronary care unit for a first Q wave AMI and treated with successful primary PTST 
on the culprit lesion (TIM13 flow restored). 2D-echocardiographic left ventricular ejectlon 
function (LVEF), assessed in the first 24 hours after PTST, was successively compared 
with LVEF at hospital discharge (after 7-10 days). Myocardial reperfusion was consid- 
ered successful when at least three of the following criteria were reached (MR.score): (I) 
early ST-resolution >50% or (2) early T-wave inversion in the frst 90 men after PTST. (3) 
reperfusion ventricular arrhythmias, (4) CK and CK-MB time-to-peak <I2 hours. Major 
Adverse Cardiac Events (MACES) were evaluated at hospital discharge. 
RESULTS: In the study population patients with PA were 75 (mean age 70.1 years 
30.7% female). No differences in age, sex or prevalence of coronary risk factors were 
ewdenced. When PA was present, higher mean MR-scores (2.47 vs 1.51 p=O.O420) and 
successful reperfusion (53.3% vs 36.1% p=O.O207) were reached, especially in associa- 
tion with early T-wave inversion I” the first 90 minutes (61.3% vs 41.7% p=O.O089). LVEF 
on admission was similarly impaired in both PA and non-PA group (39.3% vs 43.6% 
p=ns) but Incidence of early left vantricular expansion was sensibly inferor (I .4% vs 
11.1% p=O.O346). At pm-discharge 2D-echo control. per cent improvement of LVEF was 
demonstrated superior (+26.5% vs +14.8% p=O.O276), while in-hospital MACE was ag- 
nificantly limited (8.0% vs 18.5% p=O.O450). 
CONCLUSIONS: Our results suggest that in patients with AMI treated with primary 
PTST, PA induces protective effects In the ischemic myocardium, probably due to myo- 
cyte preconditioning which favours more rapid and effective reperfusion and limits infarct 
size, improving left ventricular function and in-hospital prognosis. 
1096-112 Role of Endothelial Nitric Oxide Synthase in Arterial 
Remodeling in Heart Failure 
patients. Abciximab modulates neutrophll activation, however its effect on neutrophil 
apoptosis !n UA patients has not been yet Investigated. Methods. We investigated spon- Mohamed A. Gaballa, Steven Goldman, University of Arizona Saner Heart Center, 
taneous PMN apoptosis I” 6 patients with Braunwald class IIIB UA, III 12 stable angina Tucson, AZ, Southern Arizona VA Health Care System, Tucson. AZ 
(SA) patients and 12 healthy subjects. In UA patients, PMN apoptosis was also a&- To examine the role of nitric oxide (NO) in systemic arterial remodeling in congestive 
ated 30 min after 0.25 mg/Kg IV bolus of Abciximab. Apoptosls was evaluated by flow heart failure (CHF) ,n viva, we measured arterial morphology in the resistance hindltmb 
cytometry (Annexln V-FITC, Immunotech, Marseille) after PMN isolation from peripheral vasculature in the rat coronary altery ligation model of CHF 5 days after adenoviral-medi- 
blood samples (gradient centrifugation, Polymorphprep, Nicomed). Results (median; ated gene transfer of endothelial nitric oxide synthase (eNOS). The presence of CHF 
range). PMN apoptotic rate was signlfvxntly lower in UA (18%; 11.34%). than in SA was documented with increases (PcO.05) in left ventricular (LV) end-dk&olic pressure, 
(45%; 6-81% p=O 02) and healthy subjects (50%; 25.62%, p<O.OOl). Bolus of Abciximab decreases LV systolic pressure. and LV dP/dt. In the resistance vessels, of CHF rats, 
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with internal diameters from IO-600 pm there were structural alterations with decreases 
(PcO.05) in media thtckness, nuclei density, and media area, nuclear number (n=Zl- 
124). To elucidate the possible mechanisms of vascular remodeling in CHF, NO, apopto- 
sis, and shear stress were measured. In arterial tissue from CHF rats, TUNEL positive 
cells were noted and levels of the survival protein bcl-2 wars decreased (P.zO.05). Aden- 
owral-mediated gene transfer of eNOS in the hindlimb vasculature increased (PcO.05) 
shear stress, media thickness and area, nuclear numbers, bcl-2 protein level, and 
decreased (P-zO.05) the number of TUNEL positive cells in the same size vessels. To 
define the role of NO in vascular apoptosis, we transfected bovine pulmonary artery 
endothelial cells in culture with eNOS and found increased caspase-3 activtties (2.4iO.3 
vs. 12.1*1.5 pM/mg protein/hr, n=3) compared to untreated cells. Treatment of the 
endothelial cells in culture for 24 hrs with Tumor Necrosis Factor a WFa) at 10 ngfml 
increased caspase-3 activity to 66.6+4.2 pMM/mg proteinlhr, while overexpression of 
eNOS prevented the TNFa-induction of caspase-3. Our data show that arterial remodel- 
ing occurs I” the hindlimb resistance vasculature in CHF, which can be reversed by 
eNOS overexpression. These morphologic changes are associated with altered TUNEL 
positivlty, levels of sunwal proteins, and caspase-3 activity suggesting that apoptosls 
plays an Important role in arterial remodeling in CHF. 
1096-113 Time Dependent Reduction of Myocardial Infarct Size by 
Endovascular Hypothermia in an Ischemia-Reperfusion 
Porcine Model 
Vu Huna &an, Pascale Geoffroy, Julie Lebel. Nathalie Jacob, Yahye Merhi, Jean- 
Franpois Tanguay, Montreal Heart Institute, Montreal, PO, Canada 
Background: Hypothermia induction during ischemia and before rep&won has been 
successfully tested in animal studies as a mean to reduce infarct size. However, the tim- 
ing of treatment has been shown to be critical in myocardial protection therapy. The aim 
of this study was to investigate the effect of a simple endovascular hypothenia induction 
at different time frame on infarct size in a porcine model of ischemia-reperfusion. 
Methods: 21 wines were subjected to 45 minutes of left anterior descending coronary 
occlusion with an angioplasty balloon catheter followed by 3 hours of reperiusion. Using 
a dialysis catheter inserted in the jugular vein, blood was circulated through a peristaltic 
pump immersed either in warm water in normothermic group (NO) or in ice-water in hypo- 
thermia groups at the onset of rsperfusion (HI) or 30 min before repedusion (H2). Myo- 
cardial temperature was measured using an hypodermic thermistor needle probe. Heart 
rate and left ventricle pressure were monltored. Infarct size (triphenyl tetrazolium chloride 
staining) expressed as percent of the risk area (thioflavine staining) was measured. 
Results: In the hypothermic groups, myocardial temperature was decreased and main- 
tained at 30°C. No adverse hemodynamic effect was observed. Risk areas were compa- 
rable in the normothermlc and the hypothermic groups: N0=36.0i3%. Hl=36.9+3%, 
H2=36.4+3% (p=NS). Infarct sizes were respectively 57.0*7%, 36.9*5%, and ll.Oi5% 
in NO, HI and H2 groups, respectively. While the reduction of infarct size was 61% 
between H2 and NO (p<O.OOl), only a 35 % reduction in infarct size was observed 
between Hl versus NO (p=O.O6). 
Conclusion: These results suggest that hypothermia offers a better protection during 
ischemia than during the repelfusion period. Therefore, hypothermia treatment should be 
started as soon as possible before reperfusion takes place in order to optimize reduction 
in Infarct size. 
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1097-92 Thrombectomy With Distal Protection Prior to Stenting 
Is a Novel Strategy to Obtain Optimal Reperfusion in 
Patients With Acute Myocardial Infarction 
Naoki Ito Masato Nakamura, Hirotaka Komatsu, Hiroya Nuruki, Suguru Yajima, Rintaro -1 
Nakajima, Masato Yamamoto, Takuro Takagi. Hisao Ham, Hironori Hlrai, T&u 
Yamaguchi, Ohashi Hospital, Toho Univewty School of Medicine, Tokyo, Japan 
Background: A goal of reperfwon therapy for AMI patients is to obtain TIMI 3 flow at 
both epicardial and myocardnl perfusion. RescueTM thrombectomy catheter is expected 
to protect distal embolism and no-reflow phenomenon. However, we experience some 
cases with residual thrombus after thrombectomy. The purpose of this study was to eval- 
uate the efficacy of thrombectomy with distal protection to obtain optimal myocardial rep- 
erfusion. Methods: A consecutive 92 AMI patients underwent primary angioplasty were 
studied. Subjects were divided into 3 groups by means of the use of RescueTM throm- 
bectomy catheter and with distal protectlon (control: 52, Rescue: 20, Rescue with distal 
protection: 20). To evaluate eplcardial and myocardial repeffusion after angioplasty, ST- 
segment elevation were measured from twelve-lead ECGs before angioplasty and 1 hr 
after reperfusion, and the sum of the ST-segment elevation and ST-segment resolution 
was calculated. 
Results: There were no differences in the baseline characteristics among 3 groups, 
including elapsed time, using tPA and TIMI grade before PTCA. The data of ST-segment 
resolution was as follows. 
Conclusions: Thrombectomy with RescueTM pnor to stenting is associated with early 
and greater ST resolution. ST resolution was best in thrombectomy with distal protection 
group. These findings may suggest thrombectomy with distal protection IS a useful strat- 
egy for protecting distal embolism of residual thrombus and obatining optimal myocardial 
wowfusion. 
1097-93 Mid-Term Results of Thrombus Extraction in Patients 
With ST Elevation Myocardial Infarction: One Center 
Experience With the X-SIZER Catheter System 
Euloaio Garcia, Alejandro Alvarez. Jose M. Cubero, Agustin LaCorte, Manuel Abeytua, 
Jose L. Lopez-Sendon, Es&ban Lopez de Sa. Amalia Mota, Hospital Gregorio Maranon, 
Madrid, Spain 
Background: ST resolution and optimal angiographic myocardial blush after mechanical 
reperiusion are strong predictors of good clinical outcome at sholt and midterm follow up. 
Results of standard primary PTCA are SometImes jeopardized by mobilization and embo- 
lization of the thrombotic and thrombogenic material resulting in poor myocardial perfu- 
sion reflected by persistence of ST elevation on the ECG and poor anglographic filling 
and washout of the contrast material of the IRA. 
Methods: We have analysed the results of 71 patients with STEMI (<I2 hours, shock 
excluded) treated with thrombus extraction using the X-Sizer catheter system followed by 
stent implantation and correlated the ST resolution and myocardial blush after the proce- 
dure with the incidence of adverse cardiac events and ventricular function at 6 months 
follow up. 
Results: Mean age was 61* 11 yrs 16 were in Ktllip class 11-111 and 35 had anterior infarc- 
tion. TIMI 3 after the procedure was obsewed in 67 ( 94%) and myocardial blush 3 in 52 
(59%). >50% ST resolution immediately after the procedure was obtained I” 50 out of 67 
(75%) evaluable ECG’s. At 6 months 2 oatients 13%) had died. 3 (4%) suffered a new MI. 
6 (11%) underwent target vessel revascularization and 6 (6%) were’in congestive heart 
failure. Mean left ventricular eiection fraction imoroved from 50*11% to 57*14 % at 6 
months. Myocardial blush correlated with infarct location (p=O.OZ!), diabetes (p=O.O4) and 
ST resolution (p=O.O05). >50% ST resolution was an independent predictor of less incl- 
dence on adverse cardiac events at 6 months (OR: 0.19; Cl: 0.042-0.93; p=O.O4 ). 
In conclusion: Thrombus extractlon using the X-Sizer catheter system and stent implan- 
tation IS followed by very good procedural and clinical results. Adequate myocardial per- 
fusion reflected by high rate of myocardial blush 3 and >50% ST resolution correlates 
with absence of adverse cardiac events at follow up and improvement in left ventricular 
function. 
1097-94 Effect of Distal Protection or Thrombectomy on 
Corrected Thrombolysis in Myocardial Infarction Frame 
Counts in Stenting for Acute Myocardial Infarction 
Chona H. Park, Mohamed Salem, Rajiv Jauhar, Jason Freeman, Stanley Katz, Barry 
Kaplan, Stephen Green, Donna Marchant, Lawrence Ong, North Shore University 
Hospital, Manhasset, NY, Long Island Jewish Hospital, New Hyde Park, NY 
Background: Stenting in acute myocardial infarction (AMI) can be complicated by 
increased thrombus burden which can lead to no reflow and worsened outcome. Use of 
distal protection and thrombus extraction devices theoretically minimize intracoronary 
thrombus and distal embolizatlon. Using such devices may improve antegrade coronary 
flow in AMI. This was assessed by corrected TIMI frame counts (CTFC) in successive 
patients with AMI undergoing primary or rescue stenting. Methods 231 patients under- 
went primary or rescue percutaneous interventions for AMI over the last 2 years. 
Rheolyfic thrombectomy (Angiojet) was used I” 56 cases, and Guardwire distal protec- 
tion (Percusurge) was utilized m 32 cases. 
Patients were excluded if the CTFC could not be adequately assessed angiographically 
or if the infarct vessel involved a bypass graft. 16 of 32 patients in the Percusurge group 
met study criteria, and 39 of 56 patients qualified in the Angiojet group. 99 of 231 patients 
underwent unprotected stenting without the use of distal protection or thrombectomy and 
had equivalent thrombus burden (TIMI Thrombus scorez3). Student t- testing was used 
